Lakewood-Amedex Expands Global IP Portfolio for Lead Candidate, Nu-3, Targeting Infected Diabetic Foot Ulcers
Go back to Lakewood-Amedex Expands Global IP Portfolio for Lead Candidate, Nu-3, Targeting Infected Diabetic Foot Ulcers| (NASDAQ: LABT) | Delayed: 3.06 -0.35 (10.26%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.41 | 52 Week High | $ | |||
| Open | $3.55 | 52 Week Low | $ | |||
| Day High | $3.55 | P/E | N/A | |||
| Day Low | $2.77 | EPS | $ | |||
| Volume | 2,050,032 | |||||
